foxo4-dri senolytic peptide human trial 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI alleviates age-related testosterone secretion

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

Liver damage caused by cirrhosis or hepatitis can significantly increase the bioavailability of such drugs, resulting in high plasma levels and potential toxicity if the oral dose is not reduced

August 16, 2021 Hackers offer to buy 100 million customer records of US mobile operator T-Mobile - Bellevue, Washington, USA (King County) T-Mobile USA confirms a cyber incident

Another GLP-1/GIP/glucagon receptor triagonist known as retatrutide (previously LY3437943) was developed by Eli Lilly in 2022 leading to weight loss, reduced fat mass, decreased blood glucose and insulin levels in obese mice, which was attributed to increased energy expenditure and lipid oxidation [62]

One compound of research interest is the human peptide GHK (glycyl-L-histidyl-L-lysine), a copper-binding peptide known for its diverse biological actions that have been studied in the context of aging-related diseases and conditions

Kratom ( Mitragyna Speciosa Korth.): A Description on the Ethnobotany, Alkaloid Chemistry, and Neuropharmacology, in Studies in Natural Products Chemistry